BFM 89.9

HIGHLIGHTS 
Podcast  >  Bigger Picture  >  Health & Living  >  Targeted Therapy In Cancer Treatment

Targeted Therapy In Cancer Treatment

Dato’ Dr Mohamed Ibrahim Abdul Wahid, Consultant Clinical Oncologist

12-Aug-20 16:00

Targeted Therapy In Cancer Treatment

Next generation sequencing (NGS) is a form of DNA sequencing which has various applications, including helping doctors to understand cancer mutations. The use of NGS can then help treating oncologists to decide on targeted therapy for cancer patients. To help us dive into how NGS works is consultant clinical oncologist, Dato’ Dr Mohamed Ibrahim Abdul Wahid.

Image Source: AFP

Produced by: Lim Sue Ann

Presented by: Tee Shiao Eek


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Health PolicyDiseases and ConditionsMental HealthHealthy LivingFitnessScienceMedical Innovation and Technology

Tags:  The Bigger PictureHealth & Livinggenomegenetic testingbiopsycancermutation





Play / Pause

Listen now : The 6AM Stretch

Today’s Shows



6:00 AM

The 6AM Stretch

7:00 AM

World Market Watch

Tony Nash, CEO, Complete Intelligence

7:15 AM

Morning Brief

7:30 AM

Morning Brief

Adrian Chew, ASEAN AI and Data Leader, EY

7:45 AM

Morning Brief

Ahmad Maghfur Usman, Equity Analyst, Nomura Malaysia

8:00 AM

The Breakfast Grille

Manu Bhaskaran, Founding Partner & President, Centennial Asia Advisors

8:30 AM

Morning Brief

Dr. Rachel Gong, Deputy Director, Khazanah Research Institute

8:45 AM

Morning Brief

Dr Syaza Shukri, Associate Professor, International Islamic University of Malaysia (IIUM)

9:00 AM

Opening Bell

9:15 AM

Opening Bell

9:35 AM

What's the Focus

10:05 AM

Open For Business

Isaac Kon, CEO and Founder, Heytech Sdn Bhd

11:05 AM

Resource Centre

Matt Armitage, Founder, Kulturpop

12:00 PM

Enterprise Explores

Michael Freese, Professor of Management, Asia School of Business

1:00 PM

The Breakfast Grille Repeat

Manu Bhaskaran, Founding Partner & President, Centennial Asia Advisors

2:05 PM

Front Row

tbc

2:20 PM

Front Row

tbc

3:05 PM

Good Things

Native Allies; Daniel Teoh, Founder, Native

4:05 PM

Health & Living

Why A New TB Vaccine Is An Investment Worth Making; Dr Allison Portnoy, Assistant Professor of Global Health, Boston University School of Public Health

5:00 PM

The Evening Edition

7:05 PM

The Evening Edition

7:30 PM

Just For Kicks

9:00 PM

A Bit of Culture